Evidence map›Paper›PMID 41149837›Full record

ArticleJournal of personalized medicine2025

Temporal Validation of a Plasma Diagnosis Approach for Early Alzheimer Disease Diagnosis in a Cognitive Disorder Unit.

Aleix Martí-Navia, Alejandro López, Lourdes Álvarez-Sánchez, Laura Ferré-González, Angel Balaguer, Miguel Baquero, Consuelo Cháfer-Pericás

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aleix Martí-NaviaAlzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Avda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.
Alejandro LópezAlzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Avda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.
Lourdes Álvarez-SánchezAlzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Avda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.ORCID 0000-0002-7016-9739
Laura Ferré-GonzálezAlzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Avda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.ORCID 0000-0003-4631-4761
Angel BalaguerPlataforma de Big Data, IA y Bioestadística, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
Miguel BaqueroAlzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Avda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.
Consuelo Cháfer-PericásAlzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Avda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.ORCID 0000-0002-0711-5877

Funding

Instituto de Salud Carlos III FORT23/00021Instituto de Salud Carlos III PI22/00594Ministerio de Ciencia e Innovación CNS2022-135327
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer diseasebiomarkersclinical unitdiagnosisplasmavalidation

Identifiers

PMID41149837
PMCPMC12565740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.